PRODUCTION OF AZITHROMYCIN DIHYDRATE
PROBLEM TO BE SOLVED: To obtain an azithromycin dihydrate thermodynamically stable and useful as a medicine in a high yield by adding a base to an aqueous solution of azithromycin using a specific solvent. SOLUTION: This azithromycin dihydrate is obtained by adding a base (preferably sodium hydroxid...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BANDARRA JOAO MENDEZ ZITA HEGGIE WILLIAM DR |
description | PROBLEM TO BE SOLVED: To obtain an azithromycin dihydrate thermodynamically stable and useful as a medicine in a high yield by adding a base to an aqueous solution of azithromycin using a specific solvent. SOLUTION: This azithromycin dihydrate is obtained by adding a base (preferably sodium hydroxide) to an aqueous solution of azithromycin having a pH of 1-5 and containing acetone. Preferably, the aqueous solution is formed by dissolving azithromycin in acidified water (preferably water adjusted with dilute aqueous solution of hydrochloric acid) having a pH of 1-5 and adding acetone. Preferably, the aqueous solution contains water of 3-7 volume times of a weight of azithromycin. Preferably, the weight ratio of (acetone/water) in the aqueous solution is (7/3)-(3/7). A suspension in the reagent of the resultant crystallized azithromycin is stirred at a temp. of 0-25 deg.C for 6-30 hrs to obtain the objective azithromycin dihydrate having high purity in a high yield. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH11322776A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH11322776A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH11322776A3</originalsourceid><addsrcrecordid>eNrjZFAJCPJ3CXUO8fT3U_B3U3CM8gzxCPL3jXT29FNw8fSIdAlyDHHlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxXgEehobGRkbm5maOxsSoAQCi3yOC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PRODUCTION OF AZITHROMYCIN DIHYDRATE</title><source>esp@cenet</source><creator>BANDARRA JOAO ; MENDEZ ZITA ; HEGGIE WILLIAM DR</creator><creatorcontrib>BANDARRA JOAO ; MENDEZ ZITA ; HEGGIE WILLIAM DR</creatorcontrib><description>PROBLEM TO BE SOLVED: To obtain an azithromycin dihydrate thermodynamically stable and useful as a medicine in a high yield by adding a base to an aqueous solution of azithromycin using a specific solvent. SOLUTION: This azithromycin dihydrate is obtained by adding a base (preferably sodium hydroxide) to an aqueous solution of azithromycin having a pH of 1-5 and containing acetone. Preferably, the aqueous solution is formed by dissolving azithromycin in acidified water (preferably water adjusted with dilute aqueous solution of hydrochloric acid) having a pH of 1-5 and adding acetone. Preferably, the aqueous solution contains water of 3-7 volume times of a weight of azithromycin. Preferably, the weight ratio of (acetone/water) in the aqueous solution is (7/3)-(3/7). A suspension in the reagent of the resultant crystallized azithromycin is stirred at a temp. of 0-25 deg.C for 6-30 hrs to obtain the objective azithromycin dihydrate having high purity in a high yield.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991124&DB=EPODOC&CC=JP&NR=H11322776A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991124&DB=EPODOC&CC=JP&NR=H11322776A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BANDARRA JOAO</creatorcontrib><creatorcontrib>MENDEZ ZITA</creatorcontrib><creatorcontrib>HEGGIE WILLIAM DR</creatorcontrib><title>PRODUCTION OF AZITHROMYCIN DIHYDRATE</title><description>PROBLEM TO BE SOLVED: To obtain an azithromycin dihydrate thermodynamically stable and useful as a medicine in a high yield by adding a base to an aqueous solution of azithromycin using a specific solvent. SOLUTION: This azithromycin dihydrate is obtained by adding a base (preferably sodium hydroxide) to an aqueous solution of azithromycin having a pH of 1-5 and containing acetone. Preferably, the aqueous solution is formed by dissolving azithromycin in acidified water (preferably water adjusted with dilute aqueous solution of hydrochloric acid) having a pH of 1-5 and adding acetone. Preferably, the aqueous solution contains water of 3-7 volume times of a weight of azithromycin. Preferably, the weight ratio of (acetone/water) in the aqueous solution is (7/3)-(3/7). A suspension in the reagent of the resultant crystallized azithromycin is stirred at a temp. of 0-25 deg.C for 6-30 hrs to obtain the objective azithromycin dihydrate having high purity in a high yield.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAJCPJ3CXUO8fT3U_B3U3CM8gzxCPL3jXT29FNw8fSIdAlyDHHlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxXgEehobGRkbm5maOxsSoAQCi3yOC</recordid><startdate>19991124</startdate><enddate>19991124</enddate><creator>BANDARRA JOAO</creator><creator>MENDEZ ZITA</creator><creator>HEGGIE WILLIAM DR</creator><scope>EVB</scope></search><sort><creationdate>19991124</creationdate><title>PRODUCTION OF AZITHROMYCIN DIHYDRATE</title><author>BANDARRA JOAO ; MENDEZ ZITA ; HEGGIE WILLIAM DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH11322776A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>BANDARRA JOAO</creatorcontrib><creatorcontrib>MENDEZ ZITA</creatorcontrib><creatorcontrib>HEGGIE WILLIAM DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BANDARRA JOAO</au><au>MENDEZ ZITA</au><au>HEGGIE WILLIAM DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PRODUCTION OF AZITHROMYCIN DIHYDRATE</title><date>1999-11-24</date><risdate>1999</risdate><abstract>PROBLEM TO BE SOLVED: To obtain an azithromycin dihydrate thermodynamically stable and useful as a medicine in a high yield by adding a base to an aqueous solution of azithromycin using a specific solvent. SOLUTION: This azithromycin dihydrate is obtained by adding a base (preferably sodium hydroxide) to an aqueous solution of azithromycin having a pH of 1-5 and containing acetone. Preferably, the aqueous solution is formed by dissolving azithromycin in acidified water (preferably water adjusted with dilute aqueous solution of hydrochloric acid) having a pH of 1-5 and adding acetone. Preferably, the aqueous solution contains water of 3-7 volume times of a weight of azithromycin. Preferably, the weight ratio of (acetone/water) in the aqueous solution is (7/3)-(3/7). A suspension in the reagent of the resultant crystallized azithromycin is stirred at a temp. of 0-25 deg.C for 6-30 hrs to obtain the objective azithromycin dihydrate having high purity in a high yield.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_JPH11322776A |
source | esp@cenet |
subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
title | PRODUCTION OF AZITHROMYCIN DIHYDRATE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A52%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BANDARRA%20JOAO&rft.date=1999-11-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH11322776A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |